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ABSTRACT 
 
In this paper, we investigate the relation between stock returns and R&D spending under different 
market conditions. Our empirical evidence suggests that investors’ response to R&D activities 
varies according to stock market status. 
 
Following the conventional definitions of markets, we first categorize the market into four 
different states: slightly up (up by 0-20%), bull (up by more than 20%), slightly down (down by 0-
20%), and bear (down by more than 20%). Using firms in high-tech industries from 1992 to 2009 
as our sample, we show that investors value R&D spending consistently positively only when the 
market (proxied by the S&P 500) is up. R&D is valued less in the downward market and R&D 
response coefficients even turn negative during bear markets. However, earnings response 
coefficients are consistently positive regardless of market status. The results remain unchanged 
after we control for beta, bankruptcy risk, size, and different measuring windows. Our findings 
cannot be explained by risk-based hypothesis. 
 
The study advances our understanding of the relation between stock returns and R&D activities by 
empirically documenting its variations in market valuation across different market states; 
particularly, we found empirical evidence that R&D response coefficients in the down markets are 
negative. The study also provides additional input to the ongoing debate on finding the 
appropriate accounting treatment for intangible assets. 
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1. INTRODUCTION 
 
he extant literature has provided extensive empirical evidence on the relationship between research 
and development (R&D) expenditures and future abnormal returns. As noted, both the level of R&D 
and the change of R&D activities are followed by positive risk-adjusted returns in subsequent periods. 
While some studies find that a delayed positive response to R&D activities is prevalent across industries (e.g., Hall, 
1993, Sougiannis, 1994, Lev & Sougiannis, 1996), others show the delayed positive price reaction to R&D only 
exists in certain industries, especially in R&D-intensive sectors (e.g., Chan et al., 2001). Nevertheless, it is still 
puzzling as to why and how R&D activities will be followed by abnormal returns. 
 
Two competing hypothesis exists to explain the price response to R&D activities. One strand of studies 
argues that investors have difficulties in understating the nature of R&D expenditures, resulting in a delay in 
incorporating the information in stock price efficiently. The underpricing is particularly severe for technology-based 
firms, since their intangible assets count a large percentage of total assets and their market capitalization depends 
heavily on R&D-based growth potential. Such delay also presents a challenge to accounting policymakers in 
contemplating whether R&D should be capitalized like most other major capital investments. If R&Ds can be 
capitalized, which usually requires more detailed disclosure compared to expensing, the capitalized R&D value and 
enhanced disclosure could facilitate a better understanding of R&D and allow for more timely incorporation of new 
information. Thus, the subsequent abnormal returns to R&D may be alleviated and the well-documented 
underpricing of R&D could disappear. The other strand of studies posits that the delayed R&D-return relation could 
be explained by extra risks. Kothari et al. (2002) show that the uncertainty of R&D outcomes contributes greatly to 
the volatility of operational results. Chambers, Jennings, and Thompson (2002) argue and provide empirical 
T 
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evidence that these R&D related risks are compensated with future returns. They interpret their results that R&D-
return relation could not be directly attributed to reporting manner and suggest that amending current accounting 
procedure to capitalize R&D may have no effects on improving price efficiency. 
 
In this study, we re-examine this relation in a different framework to further understand the dynamic 
between R&D activities and subsequent returns. Specifically, we investigate whether R&D expenditures are priced 
in the same fashion under different market conditions. If returns are to compensate for unexplained firm-specific 
risks, we should not expect the coefficients between abnormal returns and R&D activities to vary under different 
market conditions. On the other hand, based upon the market anomaly assumption, return-R&D relation will follow 
a random pattern regardless of the general trend of market. As shown in recent literature that many other market 
anomalies seem to relate to market sentiment (Stambaugh, Yu, & Yuan, 2012), we conjecture if future abnormal 
returns will respond more (less) to R&D intensity differently as market goes up (down). 
 
Our results are in supportive of the anomaly hypothesis. Abnormal returns only trail R&D activities when 
the market is in an upward trend. We first segment the market states into slightly up (0-20% increase), bull (more 
than 20% increase), slightly down (0-20% decrease), and bear (more than 20% decrease). Using firm-year 
observations of the high-tech industries from 1992 to 2009, we find that investors appear to price reported R&D 
expenditures positively only when markets are up between 0-20%. R&Ds are valued less in slightly down markets 
and much less in bear markets. To rule out other risk-based explanations for the R&D pricing differentials, we added 
two risk measures – beta and solvency risk (Altman-z) - to proxy market risk and financial distress risk at the firm 
level. Our results remain unchanged. 
 
We also test if our results are driven by variations of earnings rather than R&Ds. Prior literature has found 
that investment in R&D contributes more to subsequent earnings variability than investment in capital expenditures 
(Kothari, Laguerre, & Leone, 2002; Amir, Guan, & Livne, 2007). The different patterns of mispricing could have 
come from the misunderstanding of earnings rather than R&Ds. Interestingly; our findings show that earnings 
(excluding R&Ds) are priced consistently regardless of market status. Overall, our findings are in supportive of the 
view of market anomaly (mispricing). These findings shed some lights for policymakers that changing accounting 
policy to capitalize R&D expenditures may have help improve market efficiency especially during the economy 
booms. 
 
In the following sections, we first review the relevant literature and develop hypotheses in Section 2. We 
then describe the research methodology and data in Section 3. The empirical findings are presented in Section 4, and 
the concluding remarks are provided in the final section. 
 
2. LITERATURE BACKGROUND AND HYPOTHESIS 
 
Research and development (R&D) activities are generally regarded as the primary driving force of recent 
economic developments in many parts of the world including the United States. However, how capital market values 
R&D expenditures still remains puzzling to researchers. Empirical evidence shows that R&D is not efficiently 
priced by investors. Instead, it is associated with subsequent positive stock returns. Using estimated firm-specific 
R&D capital, Lev and Sougiannis (1996) show that R&D capital is positively related to future stock returns. 
However, the evidence in Chan et al. (2001) suggests that such anomaly is not prevailing among all firms. They find 
that only a subset of companies with a high ratio of R&D to market value of equity appear to earn abnormal future 
returns. In addition to the association between the level R&D spending and future abnormal returns, anomaly is 
found in valuing the changes of R&D spending as well. For example, Lev et al. (2005) show a positive relation 
between the R&D growth rate and future abnormal returns. Penman and Zhang (2002) find similar relation between 
excess returns and the ratio of change in R&D to net operating assets. Lastly, Eberhart et al. (2004) demonstrate that 
firms with large increases in R&D expenditures have higher subsequent abnormal returns. Taken together, R&D 
activities seem to be undervalued contemporaneously and followed by positive abnormal returns. Such mispricing 
anomaly is especially pronounced among firms that show high R&D intensity based on various metrics. 
 
In the literature, two different hypotheses are developed to study the contemporaneous undervaluation of 
R&D. The first is known as market anomaly assumption due to investors’ fixation. R&D expenditure is not 
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capitalized under current United States GAAP standards. Therefore, it is argued that the current accounting practice 
of expensing R&D significantly lowers the reported earnings of R&D-intensive companies. Such practice 
contributes to investor’s inability to adequately capture the real benefits of R&D activities in a timely fashion. 
Instead, we observe that, as information and benefits of R&D are gradually comprehended by market, positive 
returns follow. Such mismatch between reported accounting numbers and market reaction also prompt the 
accounting policy makers to ponder whether the current accounting treatment of R&D impedes information 
efficiency in the capital market. If the anomaly is mainly caused by the way information is convened, capitalizing 
R&D, which demands more detailed disclosures, may promote investors ability to comprehend financial reports and 
help investors grasp the true underlying economic value of R&D activities in a more timely and efficient fashion. 
The second explanation builds its argument on the embedded risk of R&D. It is argued that the relation between 
current R&D spending and future abnormal stock returns is due to the elevated risks inherent to R&D activities. For 
instance, using the firm-year observations from 1972 to 1992, Kothari et al. (2002) find R&D increases earnings 
variability in subsequent periods significantly. As well, Shi (2003) shows that R&Ds also positively relate to bond 
default risks. Furthermore, empirical evidence in Chambers, Jennings, and Thompson (2002) confirm that the 
abnormal returns to R&D-related activities appear to be long lasting rather mean reverting. Dispersions of analyst 
forecast are also greater for R&D-intensive firms. These findings, taken together, are inconsistent with the investor 
fixation induced market anomaly hypothesis, but fit with the traditional risk-return trade-off argument. Investors are 
rewarded over time for taking extra risks because of R&D activities. Abnormal future returns are indeed to 
compensate for these specific risks. 
 
We contribute to the market anomaly versus risk debate by examining the valuation of R&D across 
different market states. We argue that if abnormal returns reflect the risk inherent to R&D activities (risk hypothesis), 
we should not see differential pricing of R&D expenditures across different market states after controlling for 
systematic risk and size effects. On the other hand, market anomaly hypothesis suggests a random pattern of R&D-
return relation regardless market status. Therefore, we hypothesize that, R&D-return relation should will remain 
relatively constant and positive regardless of different market conditions (Null hypothesis). Alternatively, investors 
will respond to R&D in a random pattern (Alternative hypothesis). 
 
Moreover, a recent study by Stambaugh et al. (2012) find that many market anomalies are more 
pronounced when market sentiment is high. Given the similarity between R&D-return relation and other market 
anomalies, we expect to see lower (higher) valuation for R&D; i.e., more (less) mispricing, when the market is up 
(down) under our alternative hypothesis. As a robustness check, we examine how R&D adjusted earnings are priced 
under different market conditions. If the pricing efficiency is due to reasons other than R&D, we should not observe 
a similar pattern of our main results. 
 
3. RESEARCH METHODOLOGY 
 
3.1 Sample Selection 
 
The sample used in this study is selected from COMPUSTAT firms from 1992 to 2009, subject to data 
availability of the following variables: (1) At least two years of the monthly stock price to calculate returns; (2) at 
least two years of earnings per share to calculate change; (3) at least three years of R&D spending to satisfy the 
requirement of the lagged R&D variable used in the model; (4) industry R&D intensity; and (5) data for computing 
the debt to equity ratio. To eliminate the influence of extreme observations, cases with values falling below 1 
percentile or above 99 percentile in total assets, net sales, R&D spending, and earnings per share are excluded. 
 
Firms are defined as high-tech companies according to the metrics used by Francis and Schipper (1999).
1
 
The S&P 500 composite index was selected as the market proxy. To identify the market status, we divide general 
market conditions into the following four states: 
 
(1) BEAR: when the annual market (S&P 500) return is down at least 20%; 
(2) SLIGHTLY DOWN: when annual market return is negative but less than 20%; 
                                                 
1 Francis and Schipper (1999) define high-tech firms as firms whose SIC codes are 2800s, 3500s, 3600s, 3700s, 3800s, 4810s, 7370s, and 8730s. 
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(3) SLIGHTLY UP: when annual market return is between 0 and 20%; 
(4) BULL: when annual market return is more than 20%. 
 
In our empirical testing, each firm-year observation’s annual return is calculated from nine months before 
to three months after its fiscal year end. The following example explains how we classify each observation’s market 
state. Suppose that a firm-year observation has a fiscal year ending in December 2001; and we calculate its annual 
return from April 2001 to March 2002. The corresponding annual market return, proxied by S&P 500 index, will be 
calculated over the same period (from April 2001 to March 2002). For this specific case, since the annual market 
return was -1.1% which falls between -20% and 0%, we denote “down” market state to this firm-year observation. 
 
3.2 Model Estimated 
 
We adopt a simultaneous equation model to estimate the market valuation of R&D across different market 
states. We choose the simultaneous equation model to better control for the potential endogeneity between stock 
returns and R&D spending. Our system of equations is specified as: 
 
                                                                      
                 (1) 
 
 (2) 
 
where,  = annual stock returns accumulated from nine months before to three months after the fiscal year end; 
 = annual R&D spending in year t; 
 = earnings before R&D expense for year t; 
 = natural log of firm’s market value at the beginning of year t; 
 = debt to equity ratio of year t; 
 = the R&D intensity of the industry (four-digit SIC) where the firm is located 
 = free cash flow in year t; 
= stock beta, calculated using rates of returns 60 months prior to year t; 
 = Altman Z-score for year t; 
 represents change (the first difference); 
 
and both RD and E are scaled by sales. 
 
We run the system of equations for each market state separately. Based on the null hypothesis, the 
coefficient for R&D spending, , is expected to remain constant regardless of market states. The first seven 
independent variables in Equation (1) are typically included in the current literature to empirically examine the 
market valuation of R&D investments. To rule out the potential influence of other financial risks, especially during 
down markets, we include two risk measures as additional control variables –Beta and Altman Z-score. Beta 
captures the systematic risks associated with market volatility, and the Altman Z-score measures the financial 
distress risk and is often used predict bankruptcy. We expect the Altman Z-score to play a significant role in 
explaining returns, especially in down market states, when the market is more concerned about the risk of 
bankruptcy in bearish markets. In our empirical tests, we first run the basic model. Then, we repeat each regression 
by adding beta and Altman Z-score separately and combine both together. 
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The literature has shown that, managers may (and often) curtail or increase R&D spending to manipulate 
investors’ perceptions of firm performance (See Dechow & Sloan, 1991; Darrough & Rangan, 2005) due to its 
discretionary nature. It is difficult to argue that, in any given year, management’s determination of the level of R&D 
spending is made independently of firm equity value change. Therefore, to capture managers’ tendency to over-
invest (under-invest) in R&D due to stock price appreciation (depreciation), we include both the contemporaneous 
returns and the previous year’s returns as determinants of R&D in Equation (2). In addition, we add industry R&D 
intensity of the firm-year observation to control for common macro economic factors that may affect R&D spending 
within the same industry. Last, free cash flow is added to control for the availability of funding for R&D activities 
(Dewan et al., 1998). 
 
Because our primary focus is the response coefficient to R&D, we design our methodology to 
accommodate heterogeneous pricing of both earnings and R&D across different market states. To test the 
differential valuation of R&D across the four market states in the same equation while keeping the earnings response 
coefficient constant, we run another set of tests by modifying Equation (1) into (1B) as follows: 
 
 (1B) 
 
where: BULL = 1 if the annual S&P 500 return is equal to or greater than 20%, and 0 otherwise; 
SLIGHTLY DOWN = 1 if the annual S&P 500 return is less than 0 but greater than -20%, and 0 otherwise; 
BEAR =1 if the annual S&P 500 return is equal to or less than -20%, and 0 otherwise; 
All other variables are as defined earlier. 
 
In this alternative model, market value of R&D spending during the SLIGHTLY UP market (increase 
between 0-20%) is captured by the coefficient . The incremental market value of R&D during the BULL market, 
the SLIGHTL DOWN, and the BEAR market are then revealed by 
, , 
and 
, 
respectively. A positive  
would imply that R&D is valued higher in the BULL markets. A statistically significant negative 
, 
and  will 
indicate that the market value of R&D is lower in down markets. 
 
As to the other variables,  and  are earnings (level and change) response coefficients. Based on the 
extant accounting literature, we expect them to be positive (e.g., Easton & Harris, 1991, Ali & Zarowin, 1992).  
and , the coefficients on firm size and debt to equity ratio, respectively, are expected to be negative (e.g., Collins, 
Kothari, & Rayburn, 1987; Smith & Watts, 1992). 
 
4. EMPIRICAL RESULTS 
 
4.1 Summary Statistics 
 
Table 1 provides the number of observations included in our sample in each high-tech industry and the 
distribution of the market states by industry. Our initial sample contains a total of 41, 512 firm observations based 
on criteria described in Section 3. 
 
As Table 1 shows, the largest number of observations (firm years) are from SIC 2800 (Chemicals and 
Allied Products), SIC 3600 (Electronic and other Electric Equipment), 3500 (Industrial Machinery and Equipment), 
3800 (Measurement Instruments, Photographic Goods, and Watches), and SIC 7300 (Business Services). Table 1 
also demonstrates the independence of industry classifications and market states. There is no noticeable correlation 
between industry specifications and market states. 
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Table 1: The Distribution of Industry against Market States 
S&P 500 Annual returns (Sample period: 1992-2009) 
2-digit SIC code (Industry Name) 
<=-20% 
Bear 
-19.99%-0 
Slight Dn 
0-19.99% 
Slight Up 
>=20% 
Bull 
Total Obs. 
% of 
Sample 
28  Chemicals and Allied Products 912 436 3011 1255 5614 13.52% 
30 63 21 240 139 463 1.12% 
33 71 11 247 131 460 1.11% 
34 68 18 282 137 505 1.22% 
35  Industrial Machinery and Equipment 675 398 2474 1398 4945 11.91% 
36  Electronic and Other Electric Equipments 924 605 3122 1678 6329 15.25% 
37 Transportation Equipments 178 100 622 334 1234 2.97% 
38 Measurement Instruments, Photographic Goods, Watches 809 439 2845 1447 5540 13.35% 
48  75 28 285 124 512 1.23% 
50 93 58 414 279 844 2.03% 
51 62 25 205 168 460 1.11% 
56 13 122 179 195 509 1.23% 
58 112 49 382 272 815 1.96% 
59 87 113 348 281 829 2.00% 
73 Business Services 1129 594 3224 1684 6631 15.97% 
80 108 18 278 208 612 1.47% 
87 100 34 287 138 559 1.35% 
All other industries; each represents less than 1% of the observations 
used in the empirical tests 
526 293 
2346 
 
1486 4651 11.20% 
Total 
6005 
(14.47%) 
3362 
(8.10%) 
20791 
(50.08%) 
11354 
(27.35%) 
41512 
(100%) 
100% 
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Table 2 presents summary statistics of the sample firms. On average, firm invested 42% of its sales in R&D 
during the sample period, while the medium of sales to R&D is about 5%. The market capitalization ranges from 
$1.129 million to $58,688 million, with an average of $154 million. 
 
Table 2: Summary Statistics of the Sample (n = 41,512) 
 Mean Median Standard Deviation Minimum Maximum 
Market Capitalization (MM$) 154.467 134.137 8.457 1.129 58,688.554 
Total Assets (MM$) 1,634.258 102.873 7,593 0.036 304,012 
Net Sales (MM$) 1,490.907 96.206 6,270 0.004 200,087.635 
R&D spending (MM$) 63.931 4.700 316.930 0.000 9,694.394 
R&D intensity (R&D/NetSales) 0.422 0.054 1.930 0.000 34.19 
EPS excluding extraordinary items 0.160 0.160 10.082 -2015.4 28.43 
Net Income  before R&D to Sales - 0.102 0.075 1.102 -25.910 0.779 
Raw annual returns 0.567 -0.022 3.396 -0.965 60.767 
Excess annual returns 0.466 -0.110 3.384 -1.463 60.580 
Debt to Equity 1.080 0.611 1.681 0.000 20.342 
Beta (n = 37,464) -15.169 1.016 1297 -13186 2212.16 
Altman Z (n = 29,143) 290.127 3.511 14483 -829.90 887389 
 
Table 3 reports the identification of market states during the sample period for each cumulative annual 
returns ending month from 1992-2009. As shown, almost every sample year contains at least two different market 
states in the 12-month period. Table 4 tabulates the frequency of market states by each sample year from 1992 to 
2009 for all observations that meet our selection criteria. As shown in Table 3 and Table 4, market returns based on 
the S&P 500 during 1992-1999 are all in the positive zone and the market turned completely down in 2001 and 2002. 
Similar pattern repeated in the period of 2004-2007 (positive) and 2008-2009 (negative). About 45% of the firm-
year observations saw S&P 500 having positive returns between 0 and 19.99%.  
 
Table 3A: The Identification of Market States Based on S&P 500 Annual Returns  
During the Sample Period from 1992-1997 
 1992 1993 1994 1995 1996 1997 
January 18.9% 7.3% 9.8% -2.3% 35.2% 23.6% 
 Slightly Up Slightly Up Slightly Up Slightly Down Bull Bull 
February 12.4% 7.4% 5.4% 4.3% 31.4% 23.5% 
 Slightly Up Slightly Up Slightly Up Slightly Up Bull Bull 
March 7.6% 11.9% -1.3% 12.3% 28.9% 17.3% 
 Slightly Up Slightly Up Slightly Down Slightly Up Bull Slightly Up 
April 10.6% 6.1% 2.4% 14.1% 27.1% 22.5% 
 Slightly Up Slightly Up Slightly Up Slightly Up Bull Bull 
May 6.5% 8.4% 1.4% 16.8% 25.4% 26.8% 
 Slightly Up Slightly Up Slightly Up Slightly Up Bull Bull 
June 10.0% 10.4% -1.4% 22.6% 23.1% 32.0% 
 Slightly Up Slightly Up Slightly Down Bull Bull Bull 
July 9.4% 5.6% 2.3% 22.7% 13.9% 49.1% 
 Slightly Up Slightly Up Slightly Up Bull Slightly Up Bull 
August 4.7% 12.0% 2.6% 18.2% 16.0% 38.0% 
 Slightly Up Slightly Up Slightly Up Slightly Up Slightly Up Bull 
September 7.7% 9.8% 0.8% 26.3% 17.6% 37.8% 
 Slightly Up Slightly Up Slightly Up Bull Slightly Up Bull 
October 6.7% 11.7% 1.0% 23.1% 21.3% 29.7% 
 Slightly Up Slightly Up Slightly Up Bull Bull Bull 
November 15.0% 7.1% -1.8% 33.4% 25.1% 26.2% 
 Slightly Up Slightly Up Slightly Down Bull Bull Bull 
December 4.5% 7.1% -1.5% 34.1% 20.3% 31.0% 
 Slightly Up Slightly Up Slightly Down Bull Bull Bull 
year 1992 1993 1994 1995 1996 1997 
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Table 3B: Identification of Market States Based on S&P 500 Annual Returns During the Sample Period from 1998-2003 
 1998 1999 2000 2001 2002 2003 
January 24.7% 30.5% 9.0% -2.0% -17.3% -24.3% 
 Bull Bull Slightly Up Slightly Down Slightly Down Bear 
February 32.7% 18.0% 10.3% -9.3% -10.7% -24.0% 
 Bull Slightly Up Slightly Up Slightly Down Slightly Down Bear 
March 45.5% 16.8% 16.5% -22.6% -1.1% -26.1% 
 Bull Slightly Up Slightly Up Bear Slightly Down Bear 
April 38.7% 20.1% 8.8% -14.0% -13.8% -14.9% 
 Bull Bull Slightly Up Slightly Down Slightly Down Slightly Down 
May 28.6% 19.3% 9.1% -11.6% -15.0% -9.7% 
 Bull Slightly Up Slightly Up Slightly Down Slightly Down Slightly Down 
June 28.1% 21.1% 6.0% -15.8% -19.2% -1.5% 
 Bull Bull Slightly Up Slightly Down Slightly Down Slightly Down 
July 17.4% 18.6% 7.7% -15.3% -24.7% 8.6% 
 Slightly Up Slightly Up Slightly Up Slightly Down Bear Slightly Up 
August 6.4% 37.9% 14.9% -25.3% -19.2% 10.0% 
 Slightly Up Bull Slightly Up Bear Slightly Down Slightly Up 
September 7.4% 26.1% 12.0% -27.5% -21.7% 22.2% 
 Slightly Up Bull Slightly Up Bear Bear Bull 
October 20.1% 24.1% 4.9% -25.9% -16.4% 18.6% 
 Bull Bull Slightly Up Bear Slightly Down Slightly Up 
November 21.8% 19.4% -5.3% -13.3% -17.8% 13.0% 
 Bull Slightly Up Slightly Down Slightly Down Slightly Down Slightly Up 
December 26.7% 19.5% -10.1% -13.0% -23.4% 26.4% 
 Bull Slightly Up Slightly Down Slightly Down Bear Bull 
year 1998 1999 2000 2001 2002 2003 
 
Table 3C: Identification of Market States Based on S&P 500 Annual Returns During the Sample Period from 2004-2009 
 2004 2005 2006 2007 2008 2009 
January 32.2% 4.4% 8.4% 12.4% -4.2% -40.1% 
 Bull Slightly Up Slightly Up Slightly Up Slightly Down Bear 
February 36.1% 5.1% 6.4% 9.9% -5.4% -44.8% 
 Bull Slightly Up Slightly Up Slightly Up Slightly Down Bear 
March 32.8% 4.8% 9.7% 9.7% -6.9% -39.7% 
 Bull Slightly Up Slightly Up Slightly Up Slightly Down Bear 
April 20.8% 4.5% 13.3% 13.7% -6.5% -37.0% 
 Bull Slightly Up Slightly Up Slightly Up Slightly Down Bear 
May 16.3% 6.3% 6.6% 20.5% -8.5% -34.4% 
 Slightly Up Slightly Up Slightly Up Bull Slightly Down Bear 
June 17.1% 4.4% 6.6% 18.4% -14.9% -28.2% 
 Slightly Up Slightly Up Slightly Up Slightly Up Slightly Down Bear 
July 11.3% 12.0% 3.4% 14.0% -12.9% -22.1% 
 Slightly Up Slightly Up Slightly Up Slightly Up Slightly Down Bear 
August 9.5% 10.5% 6.8% 13.1% -13.0 -20.4% 
 Slightly Up Slightly Up Slightly Up Slightly Up Slightly Down Bear 
September 11.9% 10.2% 8.7% 14.3% -23.7% -9.2% 
 Slightly Up Slightly Up Slightly Up Slightly Up Bear Slightly Down 
October 7.6%% 6.8% 14.2% 12.4% -37.5% 7.0% 
 Slightly Up Slightly Up Slightly Up Slightly Up Bear Slightly Up 
November 10.9% 6.4% 12.1% 5.7% -39.5% 22.2% 
 Slightly Up Slightly Up Slightly Up Slightly Up Bear Bull 
December 9.0% 3.0% 13.6% 3.5% -38.5% 23.5% 
 Slightly Up Slightly Up Slightly Up Slightly Up Bear Bull 
year 2004 2005 2006 2007 2008 2009 
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Table 4: Market States Frequency by Year 
Market State* 
(firm-year observations) 
Bull 
(>=20% ) 
Slightly Up 
(0% to 19.99%) 
Slightly Down 
(-19.99% to 0) 
Bear 
(< =-20%) 
total 
1992 0 304 0 0 304 (0.7%) 
1993 0 1589 0 0 1589 (3.8%) 
1994 0 2449 0 0 2449 (5.9%) 
1995 1041 1634 0 0 2675 (6.4%) 
1996 2792 111 0 0 2903 (7.0%) 
1997 1453 1747 0 0 3200 (7.7%) 
1998 2933 419 0 0 3352 (8.1%) 
1999 1291 1907 0 0 3198 (7.7%) 
2000 0 2803 262 0 3065 (7.4%) 
2001 0 0 807 2183 2990 (7.2%) 
2002 0 0 2556 496 3052 (7.4%) 
2003 315 185 184 1835 2519 (6.1%) 
2004 1258 566 0 0 1824 (4.4%) 
2005 0 1822 0 0 1822 (4.4%) 
2006 0 1762 0 0 1762 (4.2%) 
2007 147 1542 0 0 1689 (4.1%) 
2008 0 0 1361 266 1627 (3.9%) 
2009 124 22 121 1225 1492 (3.6%) 
total 
11354 
(27.4%) 
18862 
(45.4%) 
5291 
(12.7%) 
6005 
(14.5%) 
41512 
(100%) 
* Market state is determined by S&P 500 annual returns 
 
4.2 Regression Results 
 
4.2.1 Justification for Regression Models Used 
 
In Section 3, we argue that a two-stage simultaneous equation model should be considered to test the 
hypotheses because R&D spending is discretionary, may possibly be dependent on the movement of the stock price. 
To provide statistical guidance on the choice of equation models in empirical testing, we perform Hausman’s (1978) 
Test of Specification on Equations (1) and (1B). Four methods are compared: ordinary least square (OLS), two-stage 
least square (2SLS), three-stage least square (3SLS) and seemingly unrelated regression (SUR) methodologies. The 
resulting statistics, not presented here, show that 2SLS is preferred over all the other models at a significance level 
of less than 1% for Equation (1), and that OLS is preferred over al other models for Equation (1B) at a significance 
level of less than 1%. Consequently, in the following sections, we present the outcome of our empirical testing using 
the regression models as suggested by these Hausman Tests. 
 
4.2.2 Regression Results 
 
Table 5 Panel A show the results when markets go up, and Panel B summarizes results when market goes 
down. All rows are numbered. Each market state starts with the results of the basic model, followed by the addition 
of the control variables BETA, and Z, separately and then jointly. 
 
In our hypothesis, we predict that if risk can explain the R&D return premium, market valuation of R&D 
will not vary across different market states once we control for risk. Focusing first on the coefficients for RD (level) 
across both panels, we can see the sign changes from positive in upward market states to negative in downward 
market states. Specifically, the RD coefficient goes from about 0.3 in BULL markets, to a little less than 0.1 in 
SLIGHTLY UP markets, and changes to -0.2 in SLIGHTLY DOWN markets and about -0.1 in BEAR markets. 
Except for row (12), all R&D level coefficients are statistically significant. Overall, the empirical results do not 
support the risk explanation for R&D valuation. The coefficients for the lagged variables, and RDt-2, show no 
significance, either statistically or in terms of magnitude. 
 
 
tRD
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The earnings level variable, E, is consistently statistically positive across all market states and remains 
around 0.02 to 0.06 across different market conditions, in line with the empirical results of the current literature. The 
coefficient on firm size is consistently negative across different market conditions, as expected. Debt to equity ratio 
(DE) does not appear to explain the sample high-tech firms’ excess returns except during the UP markets. Beta risk 
variable is positive in UP markets and negative in DOWN markets, a result consistent with recent finance research 
findings (e.g., Pettengill, Sundaram, & Mathur, 1995). The Altman Z-score does not show any significance except 
for row (12) when the market is DOWN. 
 
There is an apparent shift in the magnitude of the earnings response coefficient and R&D response 
coefficient across market states. The R&D response coefficient is higher than the earnings response coefficient in all 
of the BULL market regressions (rows 1 to 4). This result implies that in BULL markets, investors of high-tech 
companies focus much more on the firm value contributed by R&D than on reported earnings, which reflects firm’s 
past performance. However, the coefficient on earnings level gradually increased as the market turns towards BEAR, 
which suggest that investors appear to be more conservative and rely more on earnings as the overall market is not 
as optimistic or even pessimistic. 
 
The regression results of Equation (2), not provided here, are discussed in this paragraph. The coefficient of 
IRD, industry level R&D spending, is around 1 across different market conditions, indicating that firms in the same 
industry have similar R&D spending. There appears to be no relationship between contemporary returns or the 
previous year’s returns with current R&D spending. Contrary to intuition, the amount of free cash flow is inversely 
related to the amount of R&D spending after the other variables are controlled for. 
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Table 5: Results of 2-Stage Least Square (2SLS) Regressions 
Panel A: When Stock Market is UP (with 1% and 99% extreme measures deleted) 
Dependent variable = XRET 
Market state Intercept        Beta Altman Z Adj. R
2
 
BULL  
(row 1) 
0.59*** 0.336*** -0.000 0.001** 0.021* 0.000 -0.081*** 0.012   
3.60% 
(n=5859) 
(row 2) 
 
0.59*** 0.335*** -0.000 0.001** 0.021* 0.000 -0.081*** 0.012 0.005**  
3.68% 
(n=5852) 
(row 3) 0.59*** 0.285*** 0.006 0.002*** 0.016* 0.005 -0.080*** 0.029*  0.000 
3.42% 
(n=4023) 
(row 4) 0.59*** 0.285*** 0.006 0.001*** 0.016 0.005 -0.081*** 0.029* 0.002 0.000 
3.43% 
(n=4016) 
SLIGHTLY UP 0.48*** 0.133*** 0.000 0.000 0.018*** -0.000 -0.058*** -0.037***   
1.54% 
(n=10384) 
(row 6) 0.48*** 0.135*** 0.000 0.000 0.017*** -0.000 -0.058*** -0.037*** 0.000  
1.54% 
(n=10311) 
(row 7) 0.47*** 0.087*** -0.000 0.000 0.017** -0.000 -0.055*** -0.031***  0.000 
1.27% 
(n=8162) 
(row 8) 0.47*** 0.089*** -0.000 0.000 0.016** -0.000 -0.055*** -0.031*** 0.000 0.000 
1.25% 
(n=8091) 
Panel B: When Stock Market is DOWN (with 1% and 99% extreme measures deleted) 
Dependent variable = XRET 
Market state Intercept        Beta AltmanZ Adj. R
2
 
SLIGHTLY 
DOWN 
0.32*** -0.227** -0.002 -0.001 0.033*** -0.002 -0.019*** -0.015*   
2.20% 
(n=2624) 
(row 10) 0.51*** -0.272*** -0.039 -0.001 0.055*** -0.010** -0.033 -0.036** -0.000  
2.45% 
(n=1479) 
(row 11) 0.18*** -0.102*** -0.003 -0.001 0.028*** -0.003* -0.012* -0.008*  0.000 
1.20% 
(n=1967) 
(row 12) 0.39*** -0.063 -0.07*** 0.006 0.061*** -0.03*** -0.047*** -0.007 0.000 0.015*** 
6.70% 
(n=839) 
BEAR 0.21** -0.092*** 0.001 -0.000 0.032*** -0.000 -0.024*** -0.003   
1.49% 
(n=4567) 
(row 14) 0.23*** -0.093*** 0.001 -0.000 0.032*** -0.000 -0.026*** -0.003 -0.000  
1.54% 
(n=4311) 
(row 15) 0.09*** -0.053*** 0.003 0.000 0.026*** -0.000 -0.013*** 0.005  0.000 
1.05% 
(n=3397) 
(row 16) 0.12*** -0.055*** 0.003 0.000 0.026*** -0.001 -0.016*** 0.006 -0.000 0.000 
1.07% 
(n=3143) 
Significance levels: * 10%, **5%, ***1%  
 
tRD tRD 2tRD tE tE tSIZE tDE
tRD tRD 2tRD tE tE tSIZE tDE
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As discussed in Section 3, we also test our hypothesis using a modified model (1B) where the incremental 
market value of R&D at each market state relative to the SLIGHTLY UP market can be shown in one equation. The 
results of the modified model are provided in Table 6. 
 
In Table 6, we first look at the market valuation of R&D for the base (SLIGHTLY UP) market. The 
coefficients for RD are around 0.01. Next, we examine the market valuation of R&D at other market states relative 
to the base state by looking into the interaction term between different market states and R&D spending. Looking 
across all interaction terms, we observe that coefficient on (RD*BULL) is significantly positive in all regressions, 
adding 4% more to abnormal returns, while (RD*DOWN and RD*BEAR) are statistically significantly negative in 
most cases, revealing a price penalty for having R&D activities when market condition turns south; stated differently, 
the results imply that R&D may be perceived as expense instead of asset in the down markets. In summary, the 
results from regression model (1B) are, again, inconsistent with the risk explanation. 
 
The other variables have the same size and similar magnitude as the results presented earlier. Therefore, the 
same conclusions and interpretations still apply. 
 
Table 6: Results of Ordinary Least Square (OLS)2 Regressions (with 1% and 99% extreme measures deleted) 
Dependent variable = XRET 
 Regression 1 Regression 2 Regression 3 Regression 4 
Intercept 0.43*** 0.45*** 0.42*** 0.45*** 
 
0.016 0.013 0.026* 0.021 
 
-0.026 0.044 -0.096*** -0.031 
 
-0.116*** -0.111*** -0.158*** -0.153*** 
 0.011** 0.010** 0.006 0.005 
 0.043*** 0.043*** 0.043*** 0.043*** 
 -0.038*** 0.002 -0.026** 0.028 
 -0.015** -0.016* -0.006 -0.006*** 
 -0.000 -0.001 0.000 -0.001 
 0.001*** 0.001*** 0.001*** 0.001*** 
 0.033*** 0.034*** 0.028*** 0.029*** 
 -0.000 -0.000 -0.000 -0.000 
 -0.049*** -0.052*** -0.046*** -0.050*** 
 -0.025*** -0.027*** -0.017** -0.019** 
Beta  0.000  0.000 
Altman Z   0.000 0.000 
Adjusted R2 
N 
1.53% 
(n=33788) 
1.55% 
(n=32081) 
1.67% 
(n=24056) 
1.64% 
(n=22382) 
Significance levels: * 10%, **5%, ***1%. Variable Definitions: Bull =1 if the annual S&P 500 return is equal to or greater than 20%, and 0 
otherwise; Down = 1 if the annual S&P 500 return is less than 0 but greater than -20%, and 0 otherwise; Bear = 1 if the annual S&P 500 return is 
equal to or less than -20%, and 0 otherwise; All other variables are as defined earlier. 
 
 
 
 
                                                 
2 As discussed in Section 3, Hausman’s Specification Test results suggest that OLS is preferred over all other models for testing this equation. 
Robustness test using 2SLS to test this equation yields similar results. 
tBull
tDown
tBear
tRD
tBullRD*
tDownRD*
tBearRD*
tRD
2tRD
tE
tE
tSIZE
tDE
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4.3 Robustness Checks 
 
4.3.1 Regression Results using Other Model Specifications 
 
As demonstrated earlier, the Hausman Test of Specification suggests that the two-stage least square method 
is statistically more efficient than the ordinary least square and three-stage least square methods when all sample 
firms are used in regressions. To check for the robustness of our results, we also conduct regression analyses using 
ordinary least square and three-stage least squares for both Equations (1) and (1B). The detailed regression results 
are not provided in table format here; however, a comparison between OLS and 2SLS shows that the absolute value 
of the R&D response coefficient is slightly smaller in the OLS regressions than in 2SLS. The other variables all 
have similar coefficients. The results, using three-stage least squares, also not reported here in table form, are 
generally consistent with the results obtained when two-stage least squares are used. So the same interpretation 
applies. 
 
4.3.2 Check on Outliers 
 
Next, we test for the robustness of the results against extreme observations. We run the same regressions by 
removing extreme observations that fall below the 5% or above the 95% level for the key variables. We also 
perform the same regressions without removing any extreme observations. Both results, not presented here, are 
qualitatively similar. Thus, the previous conclusions are robust to the deletion of outliers. 
 
4.3.3 Defining “Market States” Using Different Window 
 
As market price is believed to incorporate forward-looking information, it is likely that investors may price 
current accounting information based on the anticipated market returns in the near future, instead of the current 
market state they are in. For this reason, we conduct more regressions by changing the “market states” definition to 
those based on 1-month-ahead, 1-quarter-ahead, and half-year-ahead S&P returns. The resulting statistics are 
qualitatively similar to what are being reported here. 
 
4.3.4 Using Alternative Variables in the Simultaneous Equation 
 
We also conduct regressions to find out whether replacing the change variable, R&D increment, with the 
lagged variable  last year’s R&D  would change the results. We find similar results. To find out the robustness of 
the results against an alternative specification in the endogenous variable, we replace the lagged industry R&D with 
the contemporaneous industry R&D and also find similar results. 
 
In summary, our results are robust against different simultaneous equation models, the deletion of outliers, 
different definitions of market states using different windows, as well as the use of alternative variables for R&D 
change and lagged industry R&D spending. The results that R&D is priced negatively during down markets cannot 
be explained by beta risk and Altman-Z bankruptcy risk. 
 
5. CONCLUSIONS 
 
The aim of this study is examining whether investors price R&D consistently across market states to 
understand the well-documented R&D-return relation. We collect stock and accounting variables of high-tech firms 
from 1992 to 2009 and divide the sample into four market states – BULL (more than 20% returns on S&P 500), 
SLIGHTLY UP (0% to 20% returns), SLIGHTLY DOWN (-20% to 0% returns), and BEAR (less than -20% 
returns). We examine the relation between stock returns and R&D spending across these four states after controlling 
for earnings, firm size, financial structure, beta risk, and bankruptcy risk. 
 
The empirical results show that market valuations of R&D are heterogeneous across market states. We find 
that while earnings consistently contribute to returns in a positive manner under all market states, investors value 
R&D positively when market goes up and negatively when the overall market is down after controlling for other 
risks. The results appear to be inconsistent with the risk explanation for the association between R&D spending and 
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subsequent future abnormal stock returns, but more in line with the anomaly hypothesis. Our results are also robust 
to the use of different simultaneous equation models, lagged variable, and alternative endogenous variable 
specifications. 
 
Our research is the first study in the literature to document a differential valuation to R&D across different 
market states. These findings shed light on the continuing discussions in accounting treatment in intangible assets 
and contribute to the continuing debate of risk versus anomaly in accounting and finance research. 
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